Rimas V Lukas Selected Research

Rimas V Lukas Research Topics

Disease

42	Neoplasms (Cancer) 04/2024 - 12/2006
28	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 07/2009
22	Brain Neoplasms (Brain Tumor) 04/2024 - 07/2009
19	Glioma (Gliomas) 01/2024 - 12/2006
10	Neoplasm Metastasis (Metastasis) 08/2023 - 02/2012
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 01/2014
4	Meningioma (Meningiomas) 04/2024 - 12/2020
4	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2014
3	Epilepsy (Aura) 10/2021 - 01/2016
3	Astrocytoma (Pilocytic Astrocytoma) 01/2021 - 01/2018
3	Encephalitis (Encephalitis, Rasmussen) 01/2018 - 01/2014
2	Confusion (Bewilderment) 07/2024 - 03/2017
2	Carcinogenesis 07/2023 - 12/2007
2	Seizures (Absence Seizure) 01/2023 - 01/2018
2	Circulating Neoplastic Cells 01/2023 - 02/2022
2	Hemangioblastoma 01/2023 - 09/2016
2	Lymphoma (Lymphomas) 11/2020 - 01/2018
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2019
2	Disease Progression 01/2019 - 02/2012
2	Lung Neoplasms (Lung Cancer) 09/2014 - 02/2012
1	Overweight 01/2024
1	Altitude Sickness (Mountain Sickness) 01/2024
1	von Hippel-Lindau Disease (von Hippel Lindau Disease) 01/2023
1	Brain Diseases (Brain Disorder) 01/2023
1	Arachnoiditis 01/2023
1	Anemia 01/2023
1	Neurologic Manifestations (Neurological Manifestations) 01/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2023
1	Delirium 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Amnesia (Dissociative Amnesia) 01/2021
1	Anterograde Amnesia 01/2021
1	Infarction (Infarctions) 01/2021

Drug/Important Bio-Agent (IBA)

8	Temozolomide (Temodar)FDA LinkGeneric 07/2024 - 02/2012
7	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 12/2023 - 01/2018
5	Bevacizumab (Avastin)FDA Link 12/2021 - 07/2009
4	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2023 - 01/2019
4	EnzymesIBA 12/2022 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2016
4	AntibodiesIBA 01/2018 - 01/2013
3	KynurenineIBA 01/2023 - 12/2015
3	ErbB Receptors (EGF Receptor)IBA 01/2023 - 12/2006
3	Interleukin-12 (IL 12)IBA 01/2022 - 01/2019
3	Tryptophan (L-Tryptophan)FDA Link 12/2021 - 12/2015
3	Biomarkers (Surrogate Marker)IBA 11/2021 - 11/2018
3	SteroidsIBA 11/2020 - 01/2018
3	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 10/2020 - 01/2018
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020 - 01/2014
2	Docetaxel (Taxotere)FDA Link 01/2023 - 01/2019
2	TransferasesIBA 01/2023 - 02/2009
2	Trastuzumab (Herceptin)FDA Link 01/2023 - 01/2023
2	VaccinesIBA 11/2021 - 01/2020
2	Anticonvulsants (Antiepileptic Drugs)IBA 10/2021 - 01/2018
2	epidermal growth factor receptor VIIIIBA 01/2020 - 04/2018
2	rindopepimutIBA 01/2020 - 04/2018
2	NivolumabIBA 01/2020 - 01/2018
2	atezolizumabIBA 01/2019 - 11/2018
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2018 - 01/2016
2	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2016 - 01/2013
2	N-Methylaspartate (NMDA)IBA 01/2016 - 01/2014
1	Acetazolamide (Diamox)FDA LinkGeneric 01/2024
1	ivosidenibIBA 12/2023
1	SenotherapeuticsIBA 12/2023
1	CytokinesIBA 07/2023
1	belzutifanIBA 01/2023
1	Albumin-Bound Paclitaxel FDA Link 01/2023
1	snake venom protein C activatorIBA 12/2022
1	Antidepressive Agents (Antidepressants)IBA 05/2022
1	Circulating Tumor DNAIBA 02/2022
1	veledimexIBA 01/2022
1	Complement Factor H (Factor H)IBA 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2021
1	Protein Isoforms (Isoforms)IBA 12/2021
1	EmulsionsIBA 11/2021
1	WT1 ProteinsIBA 11/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2021
1	HLA-A Antigens (HLA-A)IBA 11/2021
1	perillyl alcoholIBA 10/2021
1	Nucleic AcidsIBA 10/2021
1	Volatile Oils (Essential Oils)IBA 10/2021
1	GoldIBA 10/2021
1	SilverIBA 10/2021
1	Heroin (Diamorphine)IBA 01/2021
1	Cocaine (Cocaine HCl)IBA 01/2021
1	Opiate AlkaloidsIBA 01/2021
1	BenzodiazepinesIBA 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021

Therapy/Procedure

33	Therapeutics 04/2024 - 12/2006
16	Immunotherapy 12/2023 - 06/2015
11	Radiotherapy 01/2023 - 12/2007
7	Drug Therapy (Chemotherapy) 01/2023 - 12/2007
2	Adjuvant Radiotherapy 04/2024 - 01/2019
2	Craniotomy 01/2024 - 07/2011
2	Aftercare (After-Treatment) 12/2023 - 01/2019
1	Adjuvant Chemotherapy 06/2023
1	Drug Tapering 01/2023
1	Re-Irradiation 12/2021
1	Salvage Therapy 12/2021
1	Intravenous Administration 10/2021